Evidence map›Paper›PMID 42706234›Full record

ArticleTranslational psychiatry2026

Health behaviours and telomere biology in severe mental disorders.

Vid Mlakar, Marta Di Forti, Els F Halff, Deepak P Srivastava, Ibrahim Akkouh, Srdjan Djurovic, Carmen Martin-Ruiz, Daniel S Quintana, Viktoria Birkenæs, Nils Eiel Steen and 3 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vid MlakarSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. vid.2.mlakar@kcl.ac.uk.ORCID http://orcid.org/0009-0000-2812-621X
Marta Di FortiSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID http://orcid.org/0000-0002-3218-6925
Els F HalffSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID http://orcid.org/0000-0001-5814-0899
Deepak P SrivastavaDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID http://orcid.org/0000-0001-6512-9065
Ibrahim AkkouhDepartment of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Srdjan DjurovicDepartment of Medical Genetics, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0002-8140-8061
Carmen Martin-RuizBioScreening Core Facility-CAV, Ageing Research Laboratories, Campus for Ageing and Vitality, Newcastle University, Newcastle, UK.
Daniel S QuintanaDepartment of Psychology, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0003-2876-0004
Viktoria BirkenæsCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo, Oslo, Norway.
Nils Eiel SteenCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0001-6442-1179
Monica B E G OrmerodCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo, Oslo, Norway.
Ole A AndreassenCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-4461-3568
Monica AasSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID http://orcid.org/0000-0002-2338-5826

Funding

Norges Forskningsråd (Research Council of Norway) #223273RCUK | Medical Research Council (MRC) #MR/W027720/1
6 · The paper itself

Abstract

Alterations in telomere length (TL), a marker of cellular ageing, have been reported in individuals with severe mental disorders (SMD). Epidemiological studies of the general population have highlighted that unhealthy lifestyles may exacerbate telomere attrition. However, the impact of lifestyle on TL within the context of SMD remains unexplored. The study consisted of 410 participants (schizophrenia spectrum [n = 225] and affective disorder [n = 185]) collected as part of the Norwegian Thematically Organised Psychosis (TOP) study. Leukocyte TL was measured via blood and determined by quantitative real-time Polymerase Chain Reaction (qPCR). Patients provided self-report data on six lifestyle domains including: diet, exercise, smoking, alcohol consumption, substance use, and coffee consumption. A global dichotomised (healthy vs unhealthy) lifestyle variable was created, as well as a health behaviour variable, indicating the level of unhealthy behaviours. Individuals with an unhealthy lifestyle had shorter TL compared to those with a healthy lifestyle (Cohen's d = 0.58, F = 8.62, p = 0.004). A relationship was observed between increasing number of unhealthy behaviours and shorter TL (F = 2.69, p = 0.02), adjusted for age, sex, ethnicity, trauma exposure, medication daily defined dose (DDD), years of education and diagnosis. In terms of base-pair loss, individuals with healthy lifestyles exhibited a roughly 6-year lower biological age, compared to individuals with unhealthy lifestyles. Our study indicates that a healthier lifestyle is associated with longer TL in SMD. This highlights the importance of health behaviours as potential clinical targets for ensuring healthier cellular ageing in psychiatric populations.

Indexed as

Health BehaviorMood DisordersSchizophreniaTelomereTelomere ShorteningAdultFemaleHumansLeukocytesLife StyleMaleMiddle AgedNorway

Identifiers

PMID42706234
PMCPMC13550598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.